SCHEMBL1129487

SCHEMBL1129487

CCC(C)C(=O)NO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27270005 1.00
SCHEMBL5861940 0.80 HSD17B10 (0.41)
SCHEMBL3049838 0.79
SCHEMBL8471198 0.78
SCHEMBL103243 0.78
SCHEMBL7744271 0.78
SCHEMBL3686870 0.78
SCHEMBL11328624 0.77 ECE1 (0.40)
SCHEMBL21319394 0.77 HDAC7 (0.39)
SCHEMBL13876693 0.76 ALDH1A1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002505917-A 2002-02-26 JP claimed
EP-1061963-A1 PROTEASE INHIBITORS IN ABSORBENT ARTICLES THE PROCTER & GAMBLE COMPANY (US) 2000-12-27 EP claimed
WO-1999045974-A1 PROTEASE INHIBITORS IN ABSORBENT ARTICLES THE PROCTER & GAMBLE COMPANY (US) 1999-09-16 WO claimed
EP-0577473-B1 Reducing cosmetic composition for the permanent deformation of hair based on a mercaptoalkylamino-amide and process for the permanent deformation of hair OREAL (FR) 1995-12-20 EP claimed
EP-0577473-A1 Reducing cosmetic composition for the permanent deformation of hair based on a mercaptoalkylamino-amide and process for the permanent deformation of hair L'OREAL (FR) 1994-01-05 EP claimed
US-20240425450-A1 SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS Artizan Biosciences, Inc. 2024-12-26 US disclosed
WO-2024054845-A1 MACROCYCIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF SIONNA THERAPEUTICS (US) 2024-03-14 WO disclosed
US-20230357139-A1 SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS Artizan Biosciences, Inc. 2023-11-09 US disclosed
US-11696912-B2 Charged ion channel blockers and methods for use Nocion Therapeutics, Inc. (US) 2023-07-11 US disclosed
US-20210299112-A1 CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE NOCION THERAPEUTICS INC (US) 2021-09-30 US disclosed
CN-107382856-B Novel polysubstituted isoquinoline derivative and synthetic method thereof 江苏理工学院 2020-07-28 CN disclosed
WO-2016049565-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF RAS ARAXES PHARMA LLC (US) 2016-03-31 WO disclosed
EP-0855419-A1 Process for coating polymeric gel ELF ATOCHEM S.A. (FR) 1998-07-29 EP disclosed
EP-0822012-A1 Coating on metallic surfaces and use on tubes and cables ELF ATOCHEM S.A. (FR) 1998-02-04 EP disclosed
EP-0814487-A1 Impregnants for self-healing capacitors ELF ATOCHEM S.A. (FR) 1997-12-29 EP disclosed
EP-0784070-A1 Plasticised compound based on polyalcohol with controlled viscosity ELF ATOCHEM S.A. (FR) 1997-07-16 EP disclosed
EP-0577473-B1 Reducing cosmetic composition for the permanent deformation of hair based on a mercaptoalkylamino-amide and process for the permanent deformation of hair OREAL (FR) 1995-12-20 EP disclosed
EP-0676432-A1 Polyurethane elastomer formulation on the basis of polydiene polyols and castor oil having improved damping properties ELF ATOCHEM S.A. (FR) 1995-10-11 EP disclosed
EP-0577473-A1 Reducing cosmetic composition for the permanent deformation of hair based on a mercaptoalkylamino-amide and process for the permanent deformation of hair L'OREAL (FR) 1994-01-05 EP disclosed
US-4347342-A Process for initiating radical reactions employing hydroximic acid derivatives AKZONA INCORPORATED (US) 1982-08-31 US disclosed